Hydrocortisone Treatment for Symmetric Lipomatosis Associated With Neuropathy (SLN): an N-of-1 Study Hydrocortisone Treatment for Symmetric Lipomatosis Associated With Neuropathy (SLN): an N-of-1 Study

NCT04821583 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

1

Enrollment

OTHER

Sponsor class

Conditions

Symmetric Lipomatoses, Multiple

Interventions

DRUG: Hydrocortisone
DRUG: Placebo

Sponsor

Erasmus Medical Center